Efficacy of Tocilizumab in Primary Sjögren's Syndrome.

NCT01782235 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Primary Sjögren's Syndrome (pSS)

Interventions

DRUG: Tocilizumab
DRUG: Placebo

Sponsor

University Hospital, Strasbourg, France